Deliver Your News to the World

Myeloperoxidase Breakthroughs

WEBWIRE Lee Biosolutions, Inc manufactures in large quantities Human Myeloperoxidase and Myeloperoxidase isoforms A,B and C for clinical diagnostic, pharmaceutical manufacturers and researchers worldwide.

Current research on Myeloperoxidase protein explains how a single initial measurement of plasma myeloperoxidase (mpo), which is found in white blood cells, independently predicts the early risk of cardiovascular disease. In addition,research suggests that myeloperoxidase levels can predict the risk of major adverse cardiac events such as ischemia, myocardial infarction, and congestive heart failure, as well as heart cancer, Multiple Sclerosis, and other ailments.

Human Myeoloperoxidase MPO Isoform C is a popular enzyme among the community of protein structural researchers, including X-ray crystallographers. In order to avoid any potential confusion, these researchers prefer to specifically work with Myeloperoxidase MPO Isoform C, rather than a mixed population of MPO.

According to company President Burton Lee, Lee Biosolutions is in constant communication with its customers to determine trends and anticipate product needs before they happen. Innovative purification procedures have been developed in order to meet the demands of our clients.

We understand the critical role our products play in the clinical research process, Lee said. By maintaining higher purity and quality standards, we aim to provide clients with a wider variety of reliably consistent products which makes us the preferred producer of Myeloperoxidase products.

According to Burton Lee, President of Lee Biosolutions, Myeloperoxidase is only one of several cardiac markers which have been in high demand for some time. Lee Biosolutions supplies Native Human Myeloperoxidase, Native and recombinant Human Cardiac Troponin I,T,C, Human Creatine Kinase isoenzyme MB (CKMB) and CK MM, Lactate Dehydrogenase, Serum Amyloid P, APO A1 lipoprotein(s),human heart Myoglobin, proBNP,Alpha fetoprotein,and many other human proteins.

Lee Biosolutions is a leader in the biomaterials industry, providing the high quality products to clinical labs and researchers around the world, developing tomorrows cures. The company has provided the human proteins used in a number of high profile biomarker studies


 cardiac marker

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.